Continuous Glucose Monitoring in HIE
Recruiting
N/A
Interventional Study
Hypoxic Ischemic Encephalopathy of Newborn
Hyperglycemia
Hypoglycemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 6 Hours
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 70 (estimated)
- Sponsor
- University of Campania Luigi Vanvitelli · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the study is to examine whether the use of continuous glucose monitoring (CGM) to guide the clinical management of glycaemic control will result into an increased time in the target glucose concentration. To further examine the efficacy of using CGM the following secondary outcomes in the two groups were assessed: mean glucose values, glucose variability within individuals, percentage o…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Birth weight \>1.8kg
* Gestation \>35 weeks
* Aged \<6hours
* Moderate or severe HIE following perinatal asphyxia
Exclusion Criteria:
* Major congenital malformations
* Inborn errors of metabolism,
* Congenital infections
* Imminent death
Contacts